Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

38677-85-9

Flunixin

38677-85-9
3759-92-0

Furaltadone HCl

3759-92-0
67-45-8

Furazolidone

67-45-8
69-23-8

Fluphenazine

69-23-8
13311-84-7

Flutamide

13311-84-7
17617-23-1

Flurazepam

17617-23-1
54029-20-8

Fenbendazole Sulfone

54029-20-8
75369-61-8

5-Hydroxy Flunixin

75369-61-8
146-56-5

Fluphenazine 2HCl

146-56-5
2135-17-3

Flumethasone

2135-17-3
03/06/6990

Fusidic acid

03/06/6990
61718-82-9

Fluvoxamine Maleate

61718-82-9
183814-30-4

Formoterol fumarate 2H2O

183814-30-4
944241-52-5

Fondenafil

944241-52-5
54143-55-4

Flecainide

54143-55-4
54910-89-3

Fluoxetine

54910-89-3
93957-55-2

Fluvastatin Sodium

93957-55-2
36330-85-5

Fenbufen

36330-85-5
751-94-0

Fusidic acid sodium salt

751-94-0
3821-81-6

3-Amino-2-fluoropropionic acid

3821-81-6